2.76
|
6.23e-23
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
2.71
|
1.51e-22
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
2.67
|
1.91e-22
|
GO:0010468
|
regulation of gene expression
|
2.37
|
3.40e-22
|
GO:0080090
|
regulation of primary metabolic process
|
2.40
|
4.08e-22
|
GO:0060255
|
regulation of macromolecule metabolic process
|
2.80
|
6.21e-22
|
GO:0051252
|
regulation of RNA metabolic process
|
2.10
|
9.84e-22
|
GO:0044260
|
cellular macromolecule metabolic process
|
2.60
|
1.46e-21
|
GO:0009889
|
regulation of biosynthetic process
|
2.61
|
1.67e-21
|
GO:0031326
|
regulation of cellular biosynthetic process
|
2.32
|
7.60e-21
|
GO:0031323
|
regulation of cellular metabolic process
|
2.58
|
1.16e-20
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
2.75
|
2.27e-20
|
GO:0006355
|
regulation of transcription, DNA-dependent
|
2.56
|
2.87e-20
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
2.18
|
5.95e-20
|
GO:0019222
|
regulation of metabolic process
|
1.95
|
6.19e-19
|
GO:0043170
|
macromolecule metabolic process
|
2.97
|
6.25e-18
|
GO:0006351
|
transcription, DNA-dependent
|
2.97
|
7.05e-18
|
GO:0032774
|
RNA biosynthetic process
|
2.57
|
9.25e-17
|
GO:0016070
|
RNA metabolic process
|
2.41
|
2.23e-15
|
GO:0010467
|
gene expression
|
2.36
|
2.87e-15
|
GO:0090304
|
nucleic acid metabolic process
|
1.70
|
9.08e-14
|
GO:0044237
|
cellular metabolic process
|
2.39
|
9.74e-14
|
GO:0009059
|
macromolecule biosynthetic process
|
1.68
|
1.52e-13
|
GO:0044238
|
primary metabolic process
|
2.38
|
1.68e-13
|
GO:0034645
|
cellular macromolecule biosynthetic process
|
2.13
|
2.26e-13
|
GO:0006139
|
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
3.45
|
2.70e-13
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
1.57
|
6.63e-12
|
GO:0008152
|
metabolic process
|
1.97
|
4.99e-11
|
GO:0034641
|
cellular nitrogen compound metabolic process
|
1.95
|
5.37e-11
|
GO:0006807
|
nitrogen compound metabolic process
|
2.47
|
2.14e-09
|
GO:0006464
|
protein modification process
|
3.25
|
2.39e-09
|
GO:0010628
|
positive regulation of gene expression
|
2.42
|
2.50e-09
|
GO:0043412
|
macromolecule modification
|
1.98
|
3.28e-09
|
GO:0044249
|
cellular biosynthetic process
|
1.96
|
3.48e-09
|
GO:0009058
|
biosynthetic process
|
2.69
|
3.98e-09
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
2.22
|
4.36e-09
|
GO:0048523
|
negative regulation of cellular process
|
2.15
|
4.42e-09
|
GO:0048519
|
negative regulation of biological process
|
2.38
|
6.43e-09
|
GO:0048513
|
organ development
|
3.31
|
7.34e-09
|
GO:0045893
|
positive regulation of transcription, DNA-dependent
|
1.98
|
1.04e-08
|
GO:0007275
|
multicellular organismal development
|
3.26
|
1.20e-08
|
GO:0051254
|
positive regulation of RNA metabolic process
|
2.09
|
3.19e-08
|
GO:0048731
|
system development
|
3.24
|
8.15e-08
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
2.03
|
9.25e-08
|
GO:0048522
|
positive regulation of cellular process
|
3.29
|
9.31e-08
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
2.48
|
1.08e-07
|
GO:0009893
|
positive regulation of metabolic process
|
1.87
|
1.16e-07
|
GO:0032502
|
developmental process
|
3.14
|
1.23e-07
|
GO:0009890
|
negative regulation of biosynthetic process
|
1.45
|
1.25e-07
|
GO:0050794
|
regulation of cellular process
|
2.96
|
1.69e-07
|
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
3.27
|
2.07e-07
|
GO:0010629
|
negative regulation of gene expression
|
3.14
|
2.19e-07
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
1.42
|
2.26e-07
|
GO:0050789
|
regulation of biological process
|
2.91
|
2.67e-07
|
GO:0010557
|
positive regulation of macromolecule biosynthetic process
|
2.71
|
2.97e-07
|
GO:0009892
|
negative regulation of metabolic process
|
1.94
|
3.01e-07
|
GO:0048518
|
positive regulation of biological process
|
2.88
|
3.74e-07
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
1.94
|
6.41e-07
|
GO:0048856
|
anatomical structure development
|
2.75
|
6.68e-07
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
2.05
|
7.66e-07
|
GO:0044267
|
cellular protein metabolic process
|
9.77
|
8.54e-07
|
GO:0048704
|
embryonic skeletal system morphogenesis
|
3.14
|
1.12e-06
|
GO:0006468
|
protein phosphorylation
|
2.70
|
1.83e-06
|
GO:0031324
|
negative regulation of cellular metabolic process
|
3.36
|
1.83e-06
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
2.42
|
1.91e-06
|
GO:0031325
|
positive regulation of cellular metabolic process
|
3.80
|
2.30e-06
|
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
8.11
|
2.40e-06
|
GO:0048706
|
embryonic skeletal system development
|
2.71
|
2.53e-06
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
2.66
|
4.62e-06
|
GO:0009891
|
positive regulation of biosynthetic process
|
1.37
|
5.12e-06
|
GO:0065007
|
biological regulation
|
2.81
|
8.83e-06
|
GO:0009790
|
embryo development
|
3.15
|
8.91e-06
|
GO:0045892
|
negative regulation of transcription, DNA-dependent
|
2.99
|
1.13e-05
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
3.10
|
1.29e-05
|
GO:0051253
|
negative regulation of RNA metabolic process
|
2.95
|
1.67e-05
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
4.92
|
1.74e-05
|
GO:0071900
|
regulation of protein serine/threonine kinase activity
|
5.74
|
2.80e-05
|
GO:0048705
|
skeletal system morphogenesis
|
2.73
|
2.99e-05
|
GO:0016310
|
phosphorylation
|
3.46
|
5.97e-05
|
GO:0048598
|
embryonic morphogenesis
|
2.96
|
6.39e-05
|
GO:0042325
|
regulation of phosphorylation
|
1.81
|
7.37e-05
|
GO:0019538
|
protein metabolic process
|
2.46
|
9.37e-05
|
GO:0006796
|
phosphate metabolic process
|
2.46
|
9.93e-05
|
GO:0006793
|
phosphorus metabolic process
|
2.21
|
1.01e-04
|
GO:0009653
|
anatomical structure morphogenesis
|
3.84
|
1.12e-04
|
GO:0016568
|
chromatin modification
|
4.11
|
1.47e-04
|
GO:0001501
|
skeletal system development
|
1.23
|
1.49e-04
|
GO:0009987
|
cellular process
|
2.85
|
1.51e-04
|
GO:0019220
|
regulation of phosphate metabolic process
|
2.85
|
1.51e-04
|
GO:0051174
|
regulation of phosphorus metabolic process
|
2.28
|
1.95e-04
|
GO:0009966
|
regulation of signal transduction
|
3.65
|
2.63e-04
|
GO:0007243
|
intracellular protein kinase cascade
|
3.65
|
2.63e-04
|
GO:0023014
|
signal transduction via phosphorylation event
|
3.51
|
2.90e-04
|
GO:0045859
|
regulation of protein kinase activity
|
2.94
|
3.30e-04
|
GO:0001932
|
regulation of protein phosphorylation
|
3.46
|
3.69e-04
|
GO:0009968
|
negative regulation of signal transduction
|
3.58
|
3.76e-04
|
GO:0002520
|
immune system development
|
3.31
|
4.63e-04
|
GO:0051338
|
regulation of transferase activity
|
9.44
|
5.23e-04
|
GO:0018105
|
peptidyl-serine phosphorylation
|
2.39
|
6.10e-04
|
GO:0032268
|
regulation of cellular protein metabolic process
|
1.90
|
6.36e-04
|
GO:0030154
|
cell differentiation
|
3.31
|
8.10e-04
|
GO:0043549
|
regulation of kinase activity
|
3.03
|
8.12e-04
|
GO:0043009
|
chordate embryonic development
|
1.87
|
8.31e-04
|
GO:0048869
|
cellular developmental process
|
3.79
|
1.05e-03
|
GO:0048568
|
embryonic organ development
|
2.98
|
1.07e-03
|
GO:0009792
|
embryo development ending in birth or egg hatching
|
3.34
|
1.18e-03
|
GO:0006325
|
chromatin organization
|
12.56
|
1.39e-03
|
GO:0048701
|
embryonic cranial skeleton morphogenesis
|
2.93
|
1.51e-03
|
GO:0072358
|
cardiovascular system development
|
2.93
|
1.51e-03
|
GO:0072359
|
circulatory system development
|
3.17
|
1.70e-03
|
GO:0023057
|
negative regulation of signaling
|
3.16
|
1.77e-03
|
GO:0010648
|
negative regulation of cell communication
|
2.49
|
2.08e-03
|
GO:0045595
|
regulation of cell differentiation
|
2.24
|
2.33e-03
|
GO:0051246
|
regulation of protein metabolic process
|
4.41
|
2.36e-03
|
GO:0048562
|
embryonic organ morphogenesis
|
3.42
|
2.61e-03
|
GO:0048534
|
hemopoietic or lymphoid organ development
|
3.17
|
2.85e-03
|
GO:0045597
|
positive regulation of cell differentiation
|
7.58
|
3.56e-03
|
GO:0018209
|
peptidyl-serine modification
|
2.33
|
4.25e-03
|
GO:0009888
|
tissue development
|
1.98
|
6.36e-03
|
GO:0023051
|
regulation of signaling
|
2.42
|
7.93e-03
|
GO:0031399
|
regulation of protein modification process
|
4.55
|
8.35e-03
|
GO:0043405
|
regulation of MAP kinase activity
|
2.79
|
8.74e-03
|
GO:0048585
|
negative regulation of response to stimulus
|
2.78
|
9.38e-03
|
GO:0051276
|
chromosome organization
|
4.87
|
9.38e-03
|
GO:0071902
|
positive regulation of protein serine/threonine kinase activity
|
1.88
|
1.19e-02
|
GO:0048583
|
regulation of response to stimulus
|
3.19
|
1.28e-02
|
GO:0010551
|
regulation of gene-specific transcription from RNA polymerase II promoter
|
2.33
|
1.57e-02
|
GO:0044093
|
positive regulation of molecular function
|
3.53
|
1.89e-02
|
GO:0061061
|
muscle structure development
|
7.18
|
1.96e-02
|
GO:0016458
|
gene silencing
|
2.11
|
2.02e-02
|
GO:0050793
|
regulation of developmental process
|
3.28
|
2.64e-02
|
GO:0030097
|
hemopoiesis
|
4.06
|
2.82e-02
|
GO:0000165
|
MAPKKK cascade
|
3.25
|
3.01e-02
|
GO:0001568
|
blood vessel development
|
41.70
|
3.06e-02
|
GO:0031665
|
negative regulation of lipopolysaccharide-mediated signaling pathway
|
3.95
|
3.78e-02
|
GO:0043010
|
camera-type eye development
|
2.44
|
3.87e-02
|
GO:0006915
|
apoptosis
|
5.06
|
3.96e-02
|
GO:0043406
|
positive regulation of MAP kinase activity
|
3.49
|
4.01e-02
|
GO:0048514
|
blood vessel morphogenesis
|
7.63
|
4.50e-02
|
GO:0001649
|
osteoblast differentiation
|
2.91
|
4.61e-02
|
GO:0007389
|
pattern specification process
|
3.27
|
4.82e-02
|
GO:0051347
|
positive regulation of transferase activity
|